X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA MERCK LTD NATCO PHARMA/
MERCK LTD
 
P/E (TTM) x 33.0 26.5 124.5% View Chart
P/BV x 16.8 3.0 565.9% View Chart
Dividend Yield % 0.7 1.0 71.5%  

Financials

 NATCO PHARMA   MERCK LTD
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
MERCK LTD
Dec-16
NATCO PHARMA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs8771,060 82.7%   
Low Rs424623 68.0%   
Sales per share (Unadj.) Rs223.4632.4 35.3%  
Earnings per share (Unadj.) Rs31.145.7 68.0%  
Cash flow per share (Unadj.) Rs40.362.3 64.6%  
Dividends per share (Unadj.) Rs5.0011.00 45.5%  
Dividend yield (eoy) %0.81.3 58.8%  
Book value per share (Unadj.) Rs219.5388.8 56.5%  
Shares outstanding (eoy) m33.0716.60 199.2%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.91.3 218.7%   
Avg P/E ratio x20.918.4 113.7%  
P/CF ratio (eoy) x16.113.5 119.6%  
Price / Book Value ratio x3.02.2 136.9%  
Dividend payout %16.124.1 66.9%   
Avg Mkt Cap Rs m21,50413,969 153.9%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m1,1281,487 75.9%   
Avg. sales/employee Rs ThNM6,631.9-  
Avg. wages/employee Rs ThNM939.2-  
Avg. net profit/employee Rs ThNM479.4-  
INCOME DATA
Net Sales Rs m7,38910,498 70.4%  
Other income Rs m167242 68.9%   
Total revenues Rs m7,55610,741 70.3%   
Gross profit Rs m1,7931,135 158.0%  
Depreciation Rs m304276 110.5%   
Interest Rs m3660-   
Profit before tax Rs m1,2901,102 117.0%   
Minority Interest Rs m460-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m309343 89.9%   
Profit after tax Rs m1,027759 135.4%  
Gross profit margin %24.310.8 224.4%  
Effective tax rate %23.931.1 76.8%   
Net profit margin %13.97.2 192.4%  
BALANCE SHEET DATA
Current assets Rs m3,6816,410 57.4%   
Current liabilities Rs m3,1238,828 35.4%   
Net working cap to sales %7.6-23.0 -32.8%  
Current ratio x1.20.7 162.4%  
Inventory Days Days8958 155.1%  
Debtors Days Days5938 152.9%  
Net fixed assets Rs m7,6851,406 546.4%   
Share capital Rs m331166 199.2%   
"Free" reserves Rs m6,6706,286 106.1%   
Net worth Rs m7,2596,455 112.5%   
Long term debt Rs m9550-   
Total assets Rs m11,9578,828 135.4%  
Interest coverage x4.5NM-  
Debt to equity ratio x0.10-  
Sales to assets ratio x0.61.2 52.0%   
Return on assets %11.78.6 135.6%  
Return on equity %14.211.8 120.4%  
Return on capital %20.717.1 121.4%  
Exports to sales %39.48.3 475.2%   
Imports to sales %5.721.0 27.1%   
Exports (fob) Rs m2,908869 334.5%   
Imports (cif) Rs m4212,209 19.1%   
Fx inflow Rs m3,445959 359.3%   
Fx outflow Rs m7032,612 26.9%   
Net fx Rs m2,743-1,653 -165.9%   
CASH FLOW
From Operations Rs m1,4401,070 134.6%  
From Investments Rs m-1,089-750 145.3%  
From Financial Activity Rs m-353-150 235.4%  
Net Cashflow Rs m-1171 -0.9%  

Share Holding

Indian Promoters % 52.0 0.0 -  
Foreign collaborators % 1.5 51.8 2.8%  
Indian inst/Mut Fund % 7.8 18.2 43.1%  
FIIs % 16.6 1.0 1,663.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 29.1 89.3%  
Shareholders   25,395 28,591 88.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   STRIDES SHASUN LTD  AJANTA PHARMA  UNICHEM LAB  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 22, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS